This is a news story, published by MSN, that relates primarily to Pascal Soriot news.
For more Pascal Soriot news, you can click here:
more Pascal Soriot newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from MSN, you can click here:
more news from MSNOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
AstraZeneca CEO Pascal Soriot. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest oncology business news, new cell therapies news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
AstraZenecaCNBC
•78% Informative
AstraZeneca CEO Pascal Soriot says the company plans to release 20 new drugs by 2030 .
Soriot: "We have a large portfolio of existing products, several blockbusters...growing strongly" The company recently released promising results about several of its cancer drugs at the American Society of Clinical Oncology's annual meeting.
VR Score
73
Informative language
69
Neutral language
32
Article tone
semi-formal
Language
English
Language complexity
42
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
9
Affiliate links
no affiliate links